Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6519-6524

  Toptaş, Bahar ^a   Kurt, Özlem ^a   Aydoǧan, Ḧlya Yilmaz ^a   Yaylim, Ilhan ^a   Zeybek, Ümit ^a   Can, Ayse ^a   Agachan, Bedia ^a   Uyar, Mehmet ^b   Kerem Ozyavuz M ^b   Isbir, Turgay ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Uskudar Hospital   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Bone fragility; Osteoporosis; Paraoxonase; Polymorphism; PON1

Indexed keywords

ADENINE; ARGININE; ARYLDIALKYLPHOSPHATASE 1; ENZYME VARIANT; GLUTAMINE; GUANINE; LEUCINE; METHIONINE; THYMINE;

ADULT; ALLELE; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE METABOLISM; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME POLYMORPHISM; ETHNIC GROUP; FEMALE; GENE; HAPLOTYPE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PON1 GENE; POSTMENOPAUSE; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TURKISH;

AGED; ALLELES; ARYLDIALKYLPHOSPHATASE; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; ENZYME ACTIVATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 84892702565     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2770-5     Document Type: Article

References (32)

1. Huang QY, Kung AW (2006) Genetics of osteoporosis. Mol Genet Metab 88:295-306
2. Yamada Y, Ando F, Niino N, Miki T, Shimokata H (2003) Association of polymorphisms of paraoxonase 1 and 2 genes, alone or in combination, with bone mineral density in community-dwelling Japanese. J Hum Genet 48:469-475
3. Lorenc RS, Misiorowski W, Karczmarewicz E (2009) Critical points in strategies for the diagnosis and treatment of osteoporosis. Endokrynol Pol 60:124-133
4. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 286:2815-2822
5. Shan LP, Bee OF, Suniza SS, Adeeb N (2011) Developing a Malaysian Osteoporosis Screening Tool (MOST) for early osteoporosis detection in Malaysian women. Sex Reprod Healthc 2:77-82
6. Andrew T, Antioniades L, Scurrah KJ, MacGregor AJ, Spector TD (2005) The risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing bone mineral density. J Bone Miner Res 20:67-74
7. Deng HW, Mahaney MC, Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H, Recker RR (2002) Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Gene Epidemiol 22:12-25
8. Massart F, Reginster JY, Brandi ML (2001) Genetics of menopause-associated diseases. Maturitas 40:103-116
9. Huang QY, Recker RR, Deng HW (2003) Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos Int 14:701-715
10. Clarke B (2008) Normal bone anatomy and physiology. Clin J Am Soc Nephrol 3:131-139
11. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
12. Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL (2009) Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 284:27438-27448
13. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL (1999) Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14:2067-2078
14. Mackinnon ES, El-Sohemy A, Rao AV, Rao LG (2010) Parao-xonase 1 polymorphisms 172T/A and 584A/G modify the association between serum concentrations of the antioxidant lycopene and bone turnover markers and oxidative stress parameters in women 25-70 years of age. J Nutrigenet Nutrigenomics 3:1-8
15. Deakin SP, James RW (2004) Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 107:435-447
16. Eren Z, Kantarci G, Biyikli N, Arikan H, Tuglular S, Ergen A, Isbir T, Akoglu E (2012) Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey. Iran J Kidney Dis 6:181-185
17. Sztanek F, Seres I, Harangi M, Locsey L, Padra J, Paragh GJ, Asztalos L, Paragh G (2012) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 27:2866-2872
18. Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412-419
19. Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN (2000) Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 28:1335-1342
20. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assay for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242-247
21. Miller SA, Dykes DD, Polesky HS (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215
22. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet 3:73-76
23. Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/ary-lesterase glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598-608
24. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipo-protein against low density lipoprotein oxidative modification. FEBS Lett 423:57-60
25. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334-336
26. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE (2000) Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10:767-779
27. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62-66
28. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000) Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid arteriosclerotic lesions. Circulation 101:2510-2517
29. McGrowder D, Riley C, Morrison EY, Gordon L (2011) The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol 2011:496925
30. Kim BJ, Kim SY, Cho YS, Kim BJ, Han BG, Park EK, Lee SH, Kim HY, Kim GS, Lee JY, Koh JM (2011) Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. Exp Mol Med 28(43):71-81
31. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288: 275-279
32. Verit FF, Celik H, Yazgan P, Erel O, Geyikli I (2007) Parao-xonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 275:35-353